INSMED Inc INSM
INSMED Inc statistics & valuation
Market cap$22.4B
P / S37.0×
P / B30.3×
Net margin-210.5%
Return on equity-172.8%
FCF margin-159.6%
Net debt$36.3M
Enterprise value USD$22.4B
Earnings yield EBIT/EV-5.6%
Return on capital-69.4%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | 82.3% | 75.4% | — | — |
| Operating margin | -205.6% | -241.5% | -232.5% | -186.4% | -199.0% | -161.3% | -172.4% | -3124.9% | — | — |
| Net margin | -210.5% | -251.2% | -245.6% | -196.3% | -230.6% | -178.9% | -186.4% | -3297.2% | — | — |
| FCF margin | -159.6% | -194.1% | -180.1% | -167.2% | -196.6% | -137.2% | -214.6% | -2756.1% | — | — |
| Return on assets | -56.4% | -45.1% | -56.4% | -29.1% | -35.0% | -36.9% | -34.3% | -53.6% | -41.7% | -74.1% |
| Return on equity | -172.8% | -320.2% | 225.8% | -547.5% | -105.9% | -106.6% | -97.2% | -155.7% | -53.4% | -114.1% |
| Debt / equity | 0.74× | 3.93× | -3.55× | 13.12× | 1.95× | 1.63× | 1.72× | 2.16× | 0.15× | 0.36× |
| Current ratio | 3.83 | 5.45 | 4.12 | 6.69 | 6.19 | 5.24 | 6.51 | 6.51 | 8.72 | 6.02 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.